xMD Diagnostics
xMD Diagnostics develops advanced laboratory instruments and consumables for various markets, focusing on improving cancer and genetic disease diagnosis and treatment through automated sample preparation technology.
Company Overview
xMD Diagnostics is a company focused on developing laboratory instruments and consumables tailored to the needs of research, biopharmaceutical, and commercial clinical laboratory markets. Their mission centers on enhancing the diagnosis, monitoring, and treatment of cancer and serious genetic diseases. The company is located at the BioIncubator of the Institute of Marine and Environmental Technology in Baltimore, MD.
Innovative Technology
xMD Diagnostics offers a technology that revolutionizes manual sample preparation by transforming it into a precise, highly automated workflow. This proprietary technology, known as Expression Microdissection, is designed to isolate specific cells from samples for molecular testing. The automation and precision provided by this technology aim to significantly advance molecular diagnostics.
Funding and Grants
xMD Diagnostics has garnered financial support through various channels. They are a recipient of a MIPS grant and have received $800,000 in seed funding from The Maryland Technology Development Corporation (TEDCO). This financial backing allows them to continue their innovative work in molecular diagnostics, aiming to bring new advancements to the field.
Research and Development
The technologies and methods developed by xMD Diagnostics have supported numerous peer-reviewed publications in the field of molecular diagnostics. These contributions underscore the company's commitment to advancing scientific knowledge and improving diagnostic methodologies for serious diseases like cancer and genetic disorders.